Response to mirikizumab at Week 52 among patients who did not achieve a PASI 90 response at Week 16

Authors
Category Primary study
JournalJournal of Clinical and Aesthetic Dermatology
Year 2019
This article has no abstract
Epistemonikos ID: 7b9728d4b0262189a66261ea6ec3bf78e151e44a
First added on: Feb 11, 2025